Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01621776 · ClinicalTrials.gov registry record · NA
Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia
A NA study of Type 1 Diabetes, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT01621776 is a NA study of Type 1 Diabetes that has completed, run by University of Florida. The registered enrollment target is 107 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01621776, a NA study of Type 1 Diabetes, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to compare the post-meal blood glucose values of two drugs in a "real-world" setting.
Conditions Studied
Interventions
- DRUG Apidra
- DRUG Humalog
- DRUG Novolog
Study Locations (1)
Florida
- Camp Winona - DeLeon Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01621776
The ClinicalTrials.gov registry entry for NCT01621776 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (87% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Apidra is the first listed.
NCT01621776 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01621776 about?
NCT01621776 is a clinical study titled "Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia". This study aims to compare the post-meal blood glucose values of two drugs in a "real-world" setting.
What is the current status of trial NCT01621776?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2011-06. Estimated completion is 2012-08.
What conditions does trial NCT01621776 study?
This clinical trial studies the following conditions: Type 1 Diabetes.
What interventions are being tested in trial NCT01621776?
The interventions under investigation include: Apidra (DRUG), Humalog (DRUG), Novolog (DRUG).
Who is sponsoring clinical trial NCT01621776?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01621776 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
AIDANET Pediatrics
RECRUITING · NA
-
A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.